Thus, inhibition of ATAD3A oligomerization could reduce APP processing in AD models, consistent with reducing amyloid aggregation in both 5XFADhet;CMV;ATAD3Afl/+ mice and DA1-treated 5XFADhomo mice (Figs. 3, 4). The gene discussed is ATAD3A; the disease is Alzheimer disease.